Vamikibart

DRUG4 trials

Sponsors

Hoffmann-La Roche

Conditions

Diabetic Macular EdemaUveitic Macular Edema

Phase 2

A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema

CompletedNCT05151744

Hoffmann-La RocheDiabetic Macular Edema

Start: 2021-12-17End: 2024-10-01Updated: 2025-10-16

A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema

CompletedNCT05151731

Hoffmann-La RocheDiabetic Macular Edema

Start: 2021-12-31End: 2025-04-21Updated: 2026-05-11

Phase 3

Vamikibart in Participants With Uveitic Macular Edema

CompletedNCT05642325

Hoffmann-La RocheUveitic Macular Edema

Start: 2023-03-23End: 2025-12-24Updated: 2026-04-17

A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema

CompletedNCT05642312

Hoffmann-La RocheUveitic Macular Edema

Start: 2023-01-09End: 2025-07-09Updated: 2025-11-21

Related Papers

Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized Clinical Trial.

2026-04-09